Genomic characteristics of trastuzumab-resistant Her2-positive metastatic breast cancer.

J Cancer Res Clin Oncol · 2017 · PMC5486569 · PMID 28247034

Europe PMC DOI

hedged sentence

0.1631

closest p · 3.3× alpha

0.1631

boldest claim

The sentences

did not reach statistical significanceP = 0.1631not close (p > 0.1)

The difference in prevalence in our cohort (45.4%) and TCGA (30.8%) did not reach statistical significance ( P = 0.1631).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.